Christopher Gardner is a Senior Director at Evidera, where since July 2012, responsibilities include leading the development of global and country-specific value dossiers, HTA submissions, and market access materials across various therapy areas, such as oncology, infectious disease, cardiovascular disease, renal disease, and orphan diseases. Prior experience as a Medical/Economic Writer at Medaxial from January 2011 to August 2012 involved creating deliverables for market access, pricing, and reimbursement in multiple therapeutic areas. Christopher Gardner holds a PhD and an MRes in Neuroscience from Imperial College London along with a BSc (Hons) in Pharmacology from Newcastle University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices